CompletedPhase 3NCT00002945
High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Roswell Park Cancer Institute
- Principal Investigator
- Meir Wetzler, MDRoswell Park Cancer Institute
- Intervention
- aldesleukin(biological)
- Enrollment
- 61 enrolled
- Eligibility
- 25 years · All sexes
- Timeline
- 1996 – 2011
Study locations (1)
- Roswell Park Cancer Institute, Buffalo, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00002945 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.